173 related articles for article (PubMed ID: 10441170)
21. Identification of amino acids in the glutamate receptor, GluR3, important for antibody-binding and receptor-specific activation.
Carlson NG; Gahring LC; Twyman RE; Rogers SW
J Biol Chem; 1997 Apr; 272(17):11295-301. PubMed ID: 9111034
[TBL] [Abstract][Full Text] [Related]
22. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
[TBL] [Abstract][Full Text] [Related]
23. GluR3 autoantibodies destroy neural cells in a complement-dependent manner modulated by complement regulatory proteins.
Whitney KD; McNamara JO
J Neurosci; 2000 Oct; 20(19):7307-16. PubMed ID: 11007888
[TBL] [Abstract][Full Text] [Related]
24. Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE.
Yu P; Wellmann U; Kunder S; Quintanilla-Martinez L; Jennen L; Dear N; Amann K; Bauer S; Winkler TH; Wagner H
Int Immunol; 2006 Aug; 18(8):1211-9. PubMed ID: 16798839
[TBL] [Abstract][Full Text] [Related]
25. Autoimmune epilepsy: distinct subpopulations of epilepsy patients harbor serum autoantibodies to either glutamate/AMPA receptor GluR3, glutamate/NMDA receptor subunit NR2A or double-stranded DNA.
Ganor Y; Goldberg-Stern H; Lerman-Sagie T; Teichberg VI; Levite M
Epilepsy Res; 2005 Jun; 65(1-2):11-22. PubMed ID: 15978777
[TBL] [Abstract][Full Text] [Related]
26. GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis.
Wiendl H; Bien CG; Bernasconi P; Fleckenstein B; Elger CE; Dichgans J; Mantegazza R; Melms A
Neurology; 2001 Oct; 57(8):1511-4. PubMed ID: 11673604
[TBL] [Abstract][Full Text] [Related]
27. Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA.
Qiao B; Wu J; Chu YW; Wang Y; Wang DP; Wu HS; Xiong SD
Rheumatology (Oxford); 2005 Sep; 44(9):1108-14. PubMed ID: 15840592
[TBL] [Abstract][Full Text] [Related]
28. Genetic and immunological factors interact in a mouse model of CNS antiphospholipid syndrome.
Katzav A; Litvinjuk Y; Pick CG; Blank M; Shoenfeld Y; Sirota P; Chapman J
Behav Brain Res; 2006 May; 169(2):289-93. PubMed ID: 16530276
[TBL] [Abstract][Full Text] [Related]
29. The CD28/B7 interaction is not required for resistance to Toxoplasma gondii in the brain but contributes to the development of immunopathology.
Reichmann G; Villegas EN; Craig L; Peach R; Hunter CA
J Immunol; 1999 Sep; 163(6):3354-62. PubMed ID: 10477605
[TBL] [Abstract][Full Text] [Related]
30. Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site.
Twyman RE; Gahring LC; Spiess J; Rogers SW
Neuron; 1995 Apr; 14(4):755-62. PubMed ID: 7718238
[TBL] [Abstract][Full Text] [Related]
31. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
Atassi MZ; Oshima M; Deitiker P
Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
[TBL] [Abstract][Full Text] [Related]
32. Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus.
Hahn BH; Singh RR; Wong WK; Tsao BP; Bulpitt K; Ebling FM
Arthritis Rheum; 2001 Feb; 44(2):432-41. PubMed ID: 11229475
[TBL] [Abstract][Full Text] [Related]
33. Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein.
Rosenmann H; Grigoriadis N; Karussis D; Boimel M; Touloumi O; Ovadia H; Abramsky O
Arch Neurol; 2006 Oct; 63(10):1459-67. PubMed ID: 17030663
[TBL] [Abstract][Full Text] [Related]
34. Autoimmune Epilepsy - Novel Multidisciplinary Analysis, Discoveries and Insights.
Levite M; Goldberg H
Front Immunol; 2021; 12():762743. PubMed ID: 35095841
[TBL] [Abstract][Full Text] [Related]
35. A therapeutic anti-CD4 monoclonal antibody inhibits T cell receptor signal transduction in mouse autoimmune cardiomyopathy.
Wang ZH; Liao YH; Yuan J; Zhang L; Wang M; Zhang JH; Liu ZP; Dong JH
Chin Med J (Engl); 2007 Aug; 120(15):1319-25. PubMed ID: 17711737
[TBL] [Abstract][Full Text] [Related]
36. Late appearance of glutamate transporter defects in a murine model of ALS-parkinsonism dementia complex.
Wilson JM; Shaw CA
Neurochem Int; 2007 Jun; 50(7-8):1067-77. PubMed ID: 17095122
[TBL] [Abstract][Full Text] [Related]
37. Antibodies prepared to neuronal glutamate receptor subunit3 bind IFNalpha-receptors: implications for an autoimmune process.
Gahring LC; Carlson NG; Rogers SW
Autoimmunity; 1998; 28(4):243-8. PubMed ID: 9892506
[TBL] [Abstract][Full Text] [Related]
38. Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background.
Zhou F; He X; Iwakura Y; Horai R; Stuart JM
Arthritis Rheum; 2005 Dec; 52(12):3731-8. PubMed ID: 16320323
[TBL] [Abstract][Full Text] [Related]
39. The context of tetanus toxoid application influences the outcome of antigen-specific and self-directed humoral immune response.
Stojanović M; Zivković I; Inić-Kanada A; Petrusić V; Mićić M; Dimitrijević L
Microbiol Immunol; 2009 Feb; 53(2):89-100. PubMed ID: 19291092
[TBL] [Abstract][Full Text] [Related]
40. Glutamate receptor GluR3 antibodies and death of cortical cells.
He XP; Patel M; Whitney KD; Janumpalli S; Tenner A; McNamara JO
Neuron; 1998 Jan; 20(1):153-63. PubMed ID: 9459451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
